Cargando…
Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree
BACKGROUND: The results of two randomized phase 3 trials that investigated the use of laquinimod in patients with relapsing-remitting multiple sclerosis were analyzed using a propensity score model. METHODS: The propensity score in each study was defined as the probability of an individual patient b...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027083/ https://www.ncbi.nlm.nih.gov/pubmed/27639853 http://dx.doi.org/10.1186/s12883-016-0702-4 |